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Background. The purpose of this study was to use selected CANTAB tests to examine the 30 
dimensional structure of cognitive dysfunction in first episode of psychosis (FEP) patients 31 
compared to cognition in healthy subjects. 32 
Methods. 109 FEP patients and 96 healthy volunteers were administered eight CANTAB 33 
tests of cognitive function. Principal component analysis (PCA) was used to estimate 34 
dimensionality within the test results. The dimensions identified by the PCA were assumed to 35 
reflect underlying cognitive traits. The plausibility of latent factor models were estimated 36 
using confirmatory factor analysis (CFA). Multi-group CFA (MGCFA) was used to test for 37 
measurement invariance (MI) of factors between groups. The nature and severity of cognitive 38 
deficits amongst patients as opposed to controls were evaluated using a general linear model 39 
(GLM).  40 
Results. Amongst subjects PCA identified two underlying cognitive traits: i) a broad 41 
cognitive domain; ii) attention/memory and executive function domains. Corresponding CFA 42 
models were built that fitted data well for both FEP patients and healthy volunteers. As in 43 
MGCFA latent variables appeared differently defined in patient and control groups, 44 
differences had to be ascribed using subtest scores rather than their aggregates. At subtest 45 
score level the patients performed significantly worse than healthy subjects in all comparisons 46 
(p<0.001). 47 
Conclusions. Results of this study demonstrate that the structure of underlying cognitive 48 
abilities as measured by a selection of CANTAB tests is not the same for healthy people and 49 
FEP patients, with patients displaying widespread cognitive impairment.  50 
 51 
Keywords: Measurement invariance (MI); CANTAB; first episode psychosis (FEP); 52 
cognitive function. 53 
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Introduction 54 
Abnormalities in cognitive function have long been recognised as one of the key features of 55 
schizophrenia spectrum disorders (Gold and Harvey 1993, Saykin et al 1991), but the specific 56 
nature of this dysfunction is still not fully understood. Although there is substantial cognitive 57 
heterogeneity among schizophrenia patients (Joyce et al 2005), the typical cognitive deficit 58 
associated with chronic psychotic disorders tends to be at least moderate (Addington et al 59 
2003, Bilder et al 2000, Reichenberg et al 2002). Cognitive deficits in schizophrenia patients 60 
may be related to underlying neuronal dysfunction (Kéri and Janka 2004). Importantly, 61 
cognitive deficits may be already present before the onset of the schizophrenia (Bilder et al 62 
2000) and tend to remain relatively stable from the first episode of psychosis (typically in 63 
young adulthood) through to late middle age (Heaton et al 2001).  64 
It is unclear whether schizophrenia related cognitive deficit could be characterized as a 65 
generalized process cutting across all cognitive domains (Dickinson et al 2004, Leeson et al 66 
2009a) or as a set of relatively independent deficits in different cognitive domains (Hutton et 67 
al 1998, Saykin et al 1991), but this question might be answered by investigating the profile 68 
of cognitive deficits across multiple domains. The most frequently used method for 69 
neuropsychological data reduction involves grouping cognitive tests into conventional 70 
domains (e.g. attention, memory, executive functioning) and averaging the scores of 71 
individual standardized tests within each domain (Jaeger et al 2003). An analytical study of 72 
MATRICS (Measurement and Treatment Research to Improve Cognition in Schizophrenia) 73 
data identified speed of processing, attention/vigilance, working memory, verbal learning and 74 
memory, visual learning and memory, and reasoning and problem solving as the cognitive 75 
factors that best mark the fundamental dimensions of cognitive deficit in schizophrenia 76 
sufferers (Green et al 2004).  77 
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Despite evidence that schizophrenia related cognitive impairments can be mapped into 78 
conventional domains (Dickinson et al 2011, Genderson et al 2007), other studies have 79 
revealed that domains overlap and are not clearly distinguishable (Gold et al 1997). 80 
Schizophrenia-related cognitive impairment may have a hierarchical structure akin to how 81 
cognitive abilities are usually conceptualized in healthy people. Specific cognitive functions 82 
can be subsumed under a general cognitive (impairment) factor (Deary et al 2010) and may 83 
need to be understood within a background of a more general cognitive decline. One aim of 84 
the present study was to assess the factorial structure of cognitive functioning among patients 85 
suffering from FEP and compare it with healthy controls. 86 
Results of factorial analyses depend on the variables being analyzed. This study is based on 87 
the computer interfaced CANTAB tests (Robbins and Sahakian 1994), which have been 88 
extensively validated for assessing brain-behaviour relationships in adult populations 89 
(Robbins et al 1994, Robbins et al 1998) and shown to be sensitive to brain dysfunctions of 90 
psychiatric disorders including schizophrenia (Elliott et al 1995, Pantelis et al 1997, Stip et al 91 
2008) and FEP (Barnett et al 2005, Hutton et al 1998). Eight CANTAB tests considered likely 92 
to reflect a wide spectrum of cognitive dysfunctions among FEP patients early in their illness 93 
(before long-term antipsychotic treatment impact) were selected: Pattern Recognition 94 
Memory (PRM); Spatial Recognition Memory (SRM); Paired Associates Learning (PAL); 95 
Spatial Span (SSP); Spatial Working Memory (SWM); Stockings of Cambridge (SOC); Intra-96 
Extra Dimensional Set Shift (IED); Rapid Visual Information Processing (RVP). Our aim was 97 
to investigate how these CANTAB tests grouped into principal components and thereby 98 
purported latent factors. 99 
When scores of ostensibly latent cognitive variables are compared between groups (e.g. 100 
patients and controls), researchers assume that the observed variables define latent traits in 101 
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exactly the same way for all groups (Meredith 1993), an assumption called measurement 102 
invariance (MI). Unless MI is established, one may be comparing 'apples with oranges'.  It 103 
may for example be that selected tests form a unitary trait factor in one group but not another. 104 
To the best of our knowledge there are no available studies examining MI in cognitive factor 105 
comparisons between healthy subjects and FEP patients. Testing for MI in patient-control 106 
comparisons was another aim of this study.  107 
After establishing MI we planned to evaluate differences in cognitive factors between groups, 108 
which if MI was lacking was to be achieved by comparing patients and controls based on 109 
individual test scores.  Based on previous studies (Bilder et al 2000, Mohamed et al 1999) we 110 
expected patients' performance to be lower compared to control subjects across all cognitive 111 
domains.  112 
One aim of this study was to replicate previous research on psychotic disorders related to 113 
cognitive impairment. Given the alleged replicability crisis in psychology (Pashler and 114 
Wagenmakers 2012), such studies are badly needed. Additionally we extended the previous 115 
research of (Leeson et al 2009a) by considering structural differences in cognition between 116 
FEP patients and healthy people in order to empirically and explicitly select the most 117 
appropriate level of description for assessing psychotic disorder related cognitive impairment. 118 
The question of structural similarity across FEP patients and healthy controls, or lack of it, is 119 
also of substantive interest. For example, lack of structural similarity suggests that patients' 120 
cognition may differ qualitatively from healthy controls. 121 
 122 
Method 123 
Participants 124 
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The patient sample consisted of 109 inpatients or outpatients (54.1% males) with FEP from 125 
two psychiatry clinics in Estonia. Mean patient age was 26.9 years (S.D.=7.0, range 18-43) 126 
and 91.7% were right-handed. The patients fulfilled the following inclusion criteria: aged 127 
between 18 and 45; experience of the first psychotic episode; duration of untreated psychosis 128 
less than 3 years; no antipsychotic treatment received before the first contact with medical 129 
services for psychosis. When recruited patients were in the stabilization phase of the first 130 
psychotic episode (F23 or F20._9). Diagnoses was based on clinical interview according to 131 
ICD-10 (WHO, 1992) criteria, medical chart review, information from collateral informants, 132 
and were consented within two clinical psychiatrists. In the psychosis group the diagnoses 133 
were F23.0 (n=20), F23.1 (n=22), F23.2 (n=31), F23.3 (n=7), F23.8 (n=5), F23.9 (n=3), 134 
F20.09 (n=19), F20.29 (n=1) and F20.39 (n=1). Patients were taking antipsychotics during 135 
the neuropsychological testing. The duration of medication use did not exceed 3 months. 136 
Patients were excluded from the study if they had psychotic disorders due to a general 137 
medical condition or substance induced psychosis. 138 
A sample of 96 healthy volunteers (controls) of which 40.6% comprised males were recruited 139 
by advertisement from hospital staff and the general public. Mean age of the control group 140 
was 25.7 years (S.D.=6.4, range 18-44) and 97.9% were right-handed. The controls were 141 
questioned regarding the state of their health and medical history to exclude those with 142 
conditions that might interfere with cognitive performance. Conditions that resulted in 143 
rejection of control subjects included neurological disorders, mental retardation or significant 144 
learning disorder, and major sight and hearing impairment. Exclusion criteria for the control 145 
group also included psychotic disorder among close relatives. Both FEP and control subjects 146 
were required to have knowledge of the Estonian language. There were no statistically 147 
significant differences between controls and patients in terms of age, gender, or handedness. 148 
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The average formal educational experience was 12.9 years (S.D.=2.4) for patients and 14.0 149 
years (S.D.=2.0) for healthy subjects, a difference that was significantly significant (t = -3.51, 150 
p<0.01). 151 
All data were collected cross-sectionally. Patients and healthy subjects were enrolled between 152 
January 2009 and March 2013. All participants gave written, informed consent to take part in 153 
the study and did not receive compensation. Ethical approval was granted by the Ethic 154 
Review Committee on Human Research, University of Tartu, Estonia. 155 
Measures and procedure  156 
Computerized neuropsychological assessment  157 
Our clinical study started before the latest version of the CANTAB Schizophrenia Battery 158 
was available. The strategy we chose was to design a CANTAB based battery of tasks that 159 
would specifically assess cognitive deficit characteristics of chronic psychotic disorder. Eight 160 
computerised tasks (see above) from the CANTABeclipse version 3.0.0 were run on a 161 
personal computer with a high resolution touchscreen. All task stimuli were visual in nature, 162 
consisting of geometric designs or simple shapes, and required non-verbal responses. 163 
Instructions were given in Estonian from a literal translation of the CANTAB test manual 164 
produced by three clinical psychologists fluent in both English and Estonian. To ensure 165 
semantic equivalence of the translated and original test instructions a consensus meeting of 166 
translators was held. The battery of tasks took approximately one hour to administer. During 167 
test sessions participants were offered a short break. One of the tests (rapid visual information 168 
processing) required a response key. Participants were tested in two different research centres. 169 
The employed neuropsychological tasks are briefly described in the Supplementary materials. 170 
For more detailed descriptions of these tests see the CANTAB® website 171 
(www.cambridgecognition.com).  172 
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Statistical analysis 173 
First we compared patients and controls in terms of their demographic characteristics using 174 
Pearson's chi-square test for categorical variables and an independent sample t-test for 175 
continuous variables. Second an analysis of the co-variance structure of the measured 176 
neuropsychological tests was performed using a series of PCAs. For each PCA a parallel 177 
analysis (PA) (Horn 1965) helped determine the most appropriate number of components to 178 
be retained.  As the components were expected to be correlated each PCA was followed by an 179 
oblique (oblimin) rotation. Third to determine if PCA results were plausible reflections of 180 
latent cognitive constructs a CFA was conducted. PCAs and CFAs were done separately in 181 
healthy controls and FEP patients. Fourth MGCFA (Byrne et al 1989, Joreskog 1971, 182 
Widaman and Reise 1997) was used to assess whether: a) the structure of latent cognitive 183 
traits was similar in patients and controls; b) the mean scores of each group could be 184 
meaningfully compared (MI).  185 
As is common in MI testing (Wicherts and Dolan 2010) a series of multi-group CFA models 186 
were fitted with systematically increasing parameter equality constraints across groups (Horn 187 
and McArdle 1992, Vandenberg and Lance 2000). During MI testing configural invariance 188 
criteria were met if the same variables were associated with the same latent factors in each 189 
group. No parameter equality constraints across groups were imposed at this point other that 190 
the same tests defined the same latent constructs. The configural invariance model served as a 191 
baseline for further comparisons. Weak invariance was achieved when the factor loadings of 192 
the CANTAB tests on the latent variables could be held constant across groups without a 193 
significant deterioration of model fit. Weak invariance provides evidence that latent factors 194 
have the same meaning across groups. To establish a stronger form of invariance, scalar 195 
invariance, both factor loadings and intercepts of tests were constrained to be the same across 196 
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groups. In the case of no significant deterioration in model fit, scores of latent factors could 197 
be considered comparable across the groups. Strict invariance (residual variance invariance) 198 
which assumed the residual variances of observed variables to be the same across groups was 199 
also explored. No deterioration of model fit with strict invariance indicated that 200 
neuropsychological variables were measured with the same precision in both group. Finally, 201 
variances and covariances of the latent traits were constrained to be equal across groups to 202 
test whether the variability and inter-correlations of the latent variables were similar. Models 203 
were fitted using the robust maximum-likelihood (MLR) estimator in the 'lavaan' package 204 
(Rosseel 2012). Model fit was estimated using the chi-square (χ²) goodness-of-fit statistic (Hu 205 
and Bentler 1999), the Comparative Fit Index (CFI) (Bentler 1990) and the Root Mean 206 
Square Error of Approximation (RMSEA) (Browne and Cudeck 1993, Hu and Bentler 1999, 207 
Steiger 2000). Any given type of MI was supported when the fit of the more parsimonious 208 
model (i.e. the model with intercept equality constraints) was not significantly poorer than 209 
that of the less constrained model (i.e. the one without intercept equality constraints). 210 
Differences in model fit were tested using the chi-square difference test (Horn and McArdle 211 
1992), where a statistically significant (p<0.05) Δχ2 indicated a difference in fit. Group 212 
differences in latent factors could be estimated by fixing the mean in one group at zero and 213 
freely estimating the mean of the other group.  214 
GLMs were used to investigate group differences in subtest scores between FEP patients and 215 
controls. Subtest scores were standardized using the mean and standard deviation of the 216 
control group. Age, gender and years in education were used as covariates in comparisons of 217 
cognitive functioning. The average number of missing subtest scores per participant was very 218 
low (0.05%). All available test scores were used for all analyses. Statistical analyses were 219 
conducted using the R Statistical software package (R Development Core Team 2013).  220 
  
10 
 
Results  221 
Principal component analysis  222 
As the scree plot test and parallel analysis suggested two higher order components in controls 223 
and one component in FEP patients, both one- and two-component solutions in both groups 224 
were tested. In healthy controls five CANTAB subtest variables (PRM, PAL, SRM, RVP and 225 
SSP) primarily defined a component representing attention/memory (factor loadings 0.46 to 226 
0.73) and four variables (SWM errors, SWM strategy, SOC and IED) primarily defined a 227 
component called executive function (factor loadings 0.40 to 0.84). The two-component 228 
solution accounted for 45% of the total variance among the nine scores in the control group 229 
and 46% in the patient group (with primary loadings ranging from 0.42 to 0.76). The factor 230 
loading pattern of the patient group was different compared to the control group: two 231 
variables (PRM and PAL) primarily defined the memory component, whereas seven variables 232 
(SRM, RVP, SSP, SWM errors, SWM strategy, SOC and IED) defined the attention/executive 233 
function. Component inter-correlations also differed across groups with 0.15 for controls and 234 
0.30 for patients. Inter-correlations suggested a higher-order factor (a single common cause 235 
for all tests, underlying the memory/attention and executive function related sources of 236 
variance), especially among patients. Therefore, we also examined one-component solutions 237 
in both groups.  238 
The one component PCA also indicated a single high order factor, with all variables loaded on 239 
a broad cognitive variable with 0.19 to 0.66 in the control group and 0.30 to 0.85 in the 240 
patient group. The solution accounted for 28% and 35% of the total variance among the 241 
indicators, respectively. Thus, although the selected CANTAB test tended to cluster into two 242 
(somewhat different) groups in controls and patients, the tests could also be grouped into a 243 
single, overarching cognitive functioning domain, especially among patients. 244 
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Confirmatory factor analysis 245 
One- and two-component models derived from the PCA results (see above) were 246 
subsequently converted to latent trait models for single-group CFAs. In the two-factor model 247 
latent factors (attention/memory and executive function) were defined by the same variables 248 
for both patient and control groups (see Figure 1 a & b for factor loadings and covariance 249 
estimates). All factor loadings (excepted IED) were significant at p<0.01 (z-values ranged 250 
from 1.17 to 5.38 for controls and 2.33 to 13.14 for patients). Attention/memory and 251 
executive function had an extremely high inter-correlation (r=0.83) in the patient group, 252 
making it difficult to determine whether these factors measure meaningfully different 253 
constructs; in the control group inter-correlation of attention/memory and executive function 254 
was much lower (r=0.31). In other words, the two cognitive domains were effectively more 255 
coherent among patients, suggesting stronger evidence for a higher-order trait among them.  256 
In the one-factor model (see Figure 1 c & d)) all loadings were significantly different from 257 
zero in the patient group (z-values ranged from 2.14 to 9.00), whereas SWM-errors, SWM-258 
strategy and IED had non-significant factor loadings (p=0.09, p=0.23 and p=0.66, in 259 
respectively) in the control group, indicating this model may be less appropriate than the two-260 
factor model for the latter group.  As however both one- and two-factor models fitted well in 261 
both samples (Table 1), we decided to input both models into MGCFA.   262 
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Fig. 1. Representation of the two- and one-latent factor structural models derived from the exploratory factor analysis for control (a & c) and 
clinical sample (b & d), in respectively. Variables in boxes represent observed measures and variables in ovals represent latent variables. The paths 
from the latent constructs to the observed variables demonstrate the parameter estimates onto its representative constructs. Two-headed arrows 
connecting latent variables represent correlations between the constructs. The “e” represents the unique variance and error associated with each 
observed variable. PRM, Pattern Recognition Memory; SRM, Spatial Recognition Memory; PAL, Paired Associates Learning; SOC, Stockings of 
Cambridge; SSP, Spatial Span; SWM strategy, Spatial Working Memory, strategy score; SWM errors, Spatial Working Memory, errors score; 
IED, Intra/Extradimensional Shift; RVP, Rapid Visual Information Processing. 
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 263 
Measurement invariance 264 
For the two-factor solution, the fit of the configural MI model was good (χ²=42.610, df=50; 265 
RMSEA=0.000; CFI=1.000), suggesting it could be considered a feasible representation of 266 
the data in both groups (Table 2) and justifying the evaluation of more restrictive invariance 267 
models. Weak MI was marginally supported (Δχ²=15.676, df=9, p=0.07), indicating that 268 
factor loadings were more or less similar across groups. Strong MI was clearly not supported 269 
in the data (Δχ²=200.730, df=7, p<0.00; CFI=0.539; RMSEA=0.143), indicating that the 270 
same observed CANTAB test scores corresponded to different latent trait levels in the two 271 
groups, making comparisons of their mean latent scores effectively meaningless. As strong 272 
MI was not met, testing for stricter forms of MI were not justified. 273 
In MGCFA specifying just one latent factor, the configural MI model fitted data well (Table 274 
2). The weak measurement invariance model was accompanied by a clear drop in model fit, 275 
suggesting that stricter forms of MI would not be met and latent factor means would not be 276 
comparable across groups.  277 
 
 278 
  
14 
 
Comparison of cognitive performance 279 
As controls and patients could not be compared based on latent traits, group differences in 280 
cognitive performance were tested using GLM based on observed test scores. For each 281 
cognitive measure, age, gender and years in education were included as covariates in group 282 
comparisons (see Table 3 for the results). In general patients exhibited widespread cognitive 283 
impairments when compared to healthy control subjects: 284 
1) Attention and memory component:  285 
There was a significant main group effect for visual (PRM) and spatial recognition memory 286 
(SRM) (F4,200=5.65, p<0.001 and F4,200=7.73, p<0.001, respectively), indicating healthy 287 
controls gave a higher number of correct responses than FEP. Healthy controls also gave a 288 
higher number of correct responses than patients for the episodic memory and learning task 289 
(PAL) (F4,200=11.98, p<0.001), had greater sensitivity for detecting important sequences in the 290 
sustained attention task (RVP) (F4,199=18.02, p<0.001) and a longer spatial span length in the 291 
working memory capacity task (SSP) (F4,200=10.4, p<0.001). 292 
2) Executive function: 293 
In the cognitive planning task (SOC), healthy subjects completed more stages in the least 294 
number of moves than patients (F4,200=18.28, p<0.001). In the cognitive shifting and 295 
flexibility task (IED), there was a main group effect for the total reverse errors measures 296 
(F4,200=11.38, p<0.001). Healthy controls gave more correct responses in the spatial working 297 
memory task (SWM errors) that measured a subject’s ability to retain spatial information and 298 
manipulate remembered items in working memory (F4,200=9.92, p<0.001), and also used 299 
heuristic strategies (SWM strategy) more efficiently than patients (F4,200=8.92, p<0.001).     300 
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 301 
Overall the profile of neuropsychological impairment in FEP patients (Figure 2) was 302 
characterized by diminished processing speed (RVP) and impaired executive functioning 303 
(SWM errors, SOC and, IED). 304 
  305 
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Fig. 2. Cognitive impairment profile: performance of FEP expressed in effect sizes. PRM, Pattern Recognition Memory; SRM, Spatial 
Recognition Memory; PAL, Paired Associates Learning; SOC, Stockings of Cambridge; SSP, Spatial Span; SWM strategy, Spatial Working 
Memory, strategy score; SWM errors, Spatial Working Memory, errors score; IED, Intra/Extradimensional Shift; RVP, Rapid Visual Information 
Processing.  
The sign of the size values was changed for IED and SWM domains in order to have the dysfunctional poles in negative values.  
 306 
Discussion 307 
The purpose of this study was to investigate the structure and possible impairment of 308 
cognitive abilities of first episode psychosis (FEP) patients compared to healthy similar 309 
aged peers. Our investigation was based on nine CANTAB tests scores (PRM, SRM, 310 
PAL, IED, SOC, SSP, SWM errors, SWM strategy and, RVP) performed by tapping a 311 
computer touchscreen to measure a wide range of cognitive skills considered potentially 312 
sensitive to psychotic disorders. This study emphasizes the importance of establishing 313 
measurement invariance (MI), which can cover nuanced group differences that might 314 
otherwise remain undetected. In this study patients and controls could not be compared in 315 
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terms of their mean latent cognitive factors because the structural relations among the 316 
cognitive tests were different between the groups. 317 
The results of the exploratory PCA and subsequent single group CFA suggested the selected 318 
CANTAB test considered may group into two different cognitive factors in both groups. 319 
Whereas two relatively distinct factors (attention/memory and executive factor) appeared to 320 
be a tenable solution among controls, a single broad ability factor however was clearly 321 
evident among patients. 322 
Consistent with some previous studies (Burton et al 2013, Dickinson et al 2006, Gladsjo et al 323 
2004) our research shows that inter-correlations of cognitive domains are higher for patients 324 
with psychotic disorder than healthy controls. In other words, patients appeared to rely more 325 
heavily on general cognitive ability than on individual cognitive processes. The more 326 
homogeneous cognitive profile of patients we found may reflect a similar impairment of 327 
cognitive skills resulting from disease-related or disease-preceding processes.  328 
Our study replicated the findings of confirmatory factor analysis (CFA) for FEP (Leeson et al 329 
2009a) that revealed cognitive functioning in control and patient groups could not be 330 
explained by similar theoretical models. Studies that replicate previous research are arguably 331 
extremely valuable in their own right (Pashler and Wagenmakers 2012). We also extended the 332 
previous analysis by importantly formally testing for the presence or lack of MI across patient 333 
and control groups. Our results indicate that the cognitive differences between patients and 334 
healthy people may not be limited to general levels of cognition, there may also be structural 335 
differences. 336 
Although the MGCFA results indicated that the cognitive domains could be constructed in the 337 
same way in controls and patients (configural invariance held for both one and two- trait 338 
models), the nature of the relationships between observed test scores and their purported 339 
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underlying construct tended to be dissimilar. This suggested that the latent factor scores were 340 
not comparable because observed test scores were probably influenced by characteristics 341 
other than the latent ability. That patients' cognitive profiles were less diverse than those of 342 
healthy individuals may be a result of psychosis-related processes impacting cognitive 343 
domains in similar ways. 344 
To our knowledge this is the first study to evaluate MI when CANTAB is used to compare 345 
patients at first episode of psychosis with healthy individuals. 346 
Our results reinforce the view that there are broad cognitive deficits associated with FEP, 347 
although the deficits could not be similarly ascribed to underlying broad cognitive domains in 348 
both FEP patients and healthy people. At the group level patients exhibited worse 349 
performance than healthy controls on all measured CANTAB subtest scores, indicating 350 
substantial cognitive impairment. Performance differences remained significant even after 351 
adjusting for years of education, age and sex, which is consistent with a number of others 352 
studies (Dickinson et al 2007, Heinrichs and Zakzanis 1998, Townsend and Norman 2004).  353 
Our study found IED test scores the most discrepant variable in the CFA models, suggesting 354 
the ability to inhibit improper response and shift attention diverge from the other variables of 355 
executive function. Previous researches (Leeson et al 2009b, Murray et al 2008) have 356 
demonstrated that impaired performance in attentional set-shifting tasks (IED) is already 357 
present at the beginning of chronic psychotic disorder and remains stable over time. One 358 
explanation for early impairment of IED is that set-shifting tasks require the contribution and 359 
co-working of numerous complex cognitive processes (e.g. attention, working memory, 360 
learning, problem solving, reasoning and inhibition). Studies have suggested that impaired 361 
set-shifting correlates with working memory deficits, explaining the reversal learning 362 
difficulties especially at the early stage of the illness (Leeson et al 2009b, Pantelis et al 2009).   363 
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This study attests that CANTAB can be used in a variety of cultural contexts. Furthermore, 364 
consistency in evidence such as structural similarity across samples and wide-spread 365 
cognitive deficit in patients suggests that the applications of the tests in different setting may 366 
be more or less comparable. 367 
This study does have limitations that require consideration when interpreting the results. First 368 
the recruitment of subjects was based on opportunity rather than random sampling. Subjects 369 
in the healthy control group came from a sub-population and results may not be 370 
extrapolatable to the general Estonian populace. The clinical sample was restricted to a group 371 
of patients that were clinically stable and willing to participate in the testing. Our findings 372 
may thus not reflect the overall cognitive characteristics of patients with FEP in Estonia. The 373 
recruited patients had a large degree of heterogeneity in terms of diagnosis and medication. 374 
We did not exclude participants with comorbid conditions, for example cannabis use in the 375 
previous anamnesis, nor adjust for specific demographic characteristics as our focus was on 376 
the general factor structure of the CANTAB test battery and the comparison of differences in 377 
the selected neuropsychological tests scores between patients and healthy subjects. 378 
Second, the limited sample size may have reduced statistical power for the factor analyses. 379 
Although the number of latent dimensions may have been underestimated or factor loadings 380 
biased, most of the loadings across factors were at least moderate, indicating factors were 381 
reasonably stable.  The factor solutions identified in this investigation however accounted for 382 
only 35% (one-factor solution for patients) and 45% (two-factor solution for healthy subjects) 383 
of the total variance among the nine CANTAB tests, indicating a substantial amount of 384 
variance was not accounted for by the identified factors.  385 
Third, the current study did not assess the premorbid cognitive functioning of the patients as 386 
we lacked properly adapted existing instruments in Estonian.  387 
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Despite potential limitations however we believe our present study offers interesting results 388 
that are useful in everyday psychiatric practice. Our findings have practical significance for 389 
the broader use of CANTAB neuropsychological tests for assessing cognition at the early 390 
stage of psychotic disorder. We also recommend that studies which use CANTAB batteries do 391 
not combine latent domains when comparing FEP patients and controls, but restrict analyses 392 
to differences in the subtests. 393 
To conclude our study addresses the often ignored but critical consideration in research 394 
employing neuropsychological test batteries of a lack of MI in comparisons of psychometric 395 
analyses between nonclinical (healthy) and clinical (patients) samples. We found that there 396 
are probably qualitatively and quantitatively different cognitive patterns in the FEP patients 397 
compared to healthy subjects, and that patients exhibit widespread cognitive impairments.  398 
Our findings support continued efforts to elucidate cognitive dysfunction as a biomarker of 399 
early stage schizophrenia. 400 
 401 
Acknowledgements 402 
The authors thank the participants who volunteered their time and effort for this study, as well 403 
as colleagues for their contributions in assessing the patients. The authors thank Alexander 404 
Zharkovsky for helpful comments on an earlier draft of this article. 405 
 406 
Financical support 407 
This research received no specific grant from any funding agency, commercial or not-for-408 
profit sectors. 409 
 410 
Conflict of interests  411 
  
21 
 
None.     412 
 413 
Ethical standards 414 
The authors assert that all procedures contributing to this work comply with the ethical 415 
standards of the relevant national and institutional committees on human experimentation and 416 
with the Helsinki Declaration of 1975, as revised in 2008.  417 
 418 
 References 419 
Addington J, Brooks BL, Addington D (2003). Cognitive functioning in first episode 420 
psychosis: Initial presentation. Schizophrenia research 62, 59-64  421 
Barnett JH, Sahakian BJ, Werners U, Hill KE, Brazil R, Gallagher O, Bullmore ET, 422 
Jones PB (2005). Visuospatial learning and executive function are independently impaired in 423 
first-episode psychosis. Psychological medicine 35, 1031-1041  424 
Bentler PM (1990). Comparative fit indexes in structural models. Psychological bulletin 107, 425 
238-246  426 
Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA, Pappadopulos E, 427 
Willson DF, Alvir JMJ, Woerner MG, Geisler S, Kane JM, Lieberman JA (2000). 428 
Neuropsychology of first-episode schizophrenia: Initial characterization and clinical 429 
correlates. The American Journal of Psychiatry 157, 549-559  430 
Browne MW, Cudeck R (1993). Testing Structural Equation Models. In Alternative ways of 431 
assessing model fit (eds. K. A. Bollen, J. S. Long), pp. 136-162. Sage: Beverly Hills,  432 
Burton CZ, Vella L, Harvey PD, Patterson TL, Heaton RK, Twamley EW (2013). Factor 433 
structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia. 434 
Schizophrenia research 146, 244-248  435 
Byrne BM, Shavelson RJ, Muthén B (1989). Testing for the equivalence of factor 436 
covariance and mean structures: The issue of partial measurement invariance. Psychological 437 
bulletin 105, 456-466  438 
Deary IJ, Penke L, Johnson W (2010). The neuroscience of human intelligence differences. 439 
Nature Reviews.Neuroscience 11, 201-211  440 
  
22 
 
Dickinson D, Goldberg TE, Gold JM, Elvevåg B, Weinberger DR (2011). Cognitive 441 
factor structure and invariance in people with schizophrenia, their unaffected siblings, and 442 
controls. Schizophrenia bulletin 37, 1157-1167  443 
Dickinson D, Iannone VN, Wilk CM, Gold JM (2004). General and specific cognitive 444 
deficits in schizophrenia. Biological psychiatry 55, 826-833  445 
Dickinson D, Ragland JD, Calkins ME, Gold JM, Gur RC (2006). A comparison of 446 
cognitive structure in schizophrenia patients and healthy controls using confirmatory factor 447 
analysis. Schizophrenia research 85, 20-29  448 
Dickinson D, Ramsey ME, Gold JM (2007). Overlooking the obvious: A meta-analytic 449 
comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. 450 
Archives of General Psychiatry 64, 532-542  451 
Elliott R, McKenna PJ, Robbins TW, Sahakian BJ (1995). Neuropsychological evidence 452 
for frontostriatal dysfunction in schizophrenia. Psychological medicine 25, 619-630  453 
Genderson MR, Dickinson D, Diaz-Asper C, Egan MF, Weinberger DR, Goldberg TE 454 
(2007). Factor analysis of neurocognitive tests in a large sample of schizophrenic probands, 455 
their siblings, and healthy controls. Schizophrenia research 94, 231-239  456 
Gladsjo JA, McAdams LA, Palmer BW, Moore DJ, Jeste DV, Heaton RK (2004). A Six-457 
Factor Model of Cognition in Schizophrenia and Related Psychotic Disorders: Relationships 458 
With Clinical Symptoms and Functional Capacity. Schizophrenia bulletin 30, 739-754  459 
Gold JM, Carpenter C, Randolph C, Goldberg TE, Weinberger DR (1997). Auditory 460 
working memory and Wisconsin Card Sorting Test performance in schizophrenia. Archives of 461 
General Psychiatry 54, 159-165  462 
Gold JM, Harvey PD (1993). Cognitive deficits in schizophrenia. Psychiatric Clinics of 463 
North America 16, 295-312  464 
Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, 465 
Frese F, Goldberg TE, Heaton RK, Keefe RSE, Kern RS, Kraemer H, Stover E, 466 
Weinberger DR, Zalcman S, Marder SR (2004). Approaching a consensus cognitive 467 
battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select 468 
cognitive domains and test criteria. Biological psychiatry 56, 301-307  469 
Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD, Jeste DV (2001). Stability 470 
and course of neuropsychological deficits in schizophrenia. Archives of General Psychiatry 471 
58, 24-32  472 
Heinrichs RW, Zakzanis KK (1998). Neurocognitive deficit in schizophrenia: A 473 
quantitative review of the evidence. Neuropsychology 12, 426-445  474 
Horn JL (1965). A rationale and test for the number of factors in factor analysis. 475 
Psychometrika 30, 179-185  476 
  
23 
 
Horn JL, McArdle JJ (1992). A practical and theoretical guide to measurement invariance 477 
in aging research. Experimental aging research 18, 117-144  478 
Hu L, Bentler PM (1999). Cutoff criteria for fit indexes in covariance structure analysis: 479 
Conventional criteria versus new alternatives. Structural Equation Modeling 6, 1-55  480 
Hutton SB, Puri BK, Duncan L-, Robbins TW, Barnes TRE, Joyce EM (1998). Executive 481 
function in first-episode schizophrenia. Psychological medicine 28, 463-473  482 
Jaeger J, Czobor Pá, Berns SM (2003). Basic neuropsychological dimensions in 483 
schizophrenia. Schizophrenia research 65, 105-116  484 
Joreskog KG (1971). Simultaneous factor analysis in several populations. Psychometrika 36, 485 
409-426  486 
Joyce EM, Hutton SB, Mutsatsa SH, Barnes TRE (2005). Cognitive heterogeneity in first-487 
episode schizophrenia. The British Journal of Psychiatry 187, 516-522  488 
Kéri S, Janka Z (2004). Critical evaluation of cognitive dysfunctions as endophenotypes of 489 
schizophrenia. Acta Psychiatrica Scandinavica 110, 83-91  490 
Leeson VC, Robbins TW, Franklin C, Harrison M, Harrison I, Ron MA, Barnes TRE, 491 
Joyce EM (2009a). Dissociation of long-term verbal memory and fronto-executive 492 
impairment in first-episode psychosis. Psychological medicine 39, 1799-1808  493 
Leeson VC, Robbins TW, Matheson E, Hutton SB, Ron MA, Barnes TRE, Joyce EM 494 
(2009b). Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: 495 
Stability over six years and specific associations with medication type and disorganization 496 
syndrome. Biological psychiatry 66, 586-593  497 
Meredith W (1993). Measurement invariance, factor analysis and factorial invariance. 498 
Psychometrika 58, 525-543  499 
Mohamed S, Paulsen JS, O'Leary D, Arndt S, Andreasen N (1999). Generalized cognitive 500 
deficits in schizophrenia: A study of first-episode patients. Archives of General Psychiatry 501 
56, 749-754  502 
Murray GK, Cheng F, Clark L, Barnett JH, Blackwell AD, Fletcher PC, Robbins TW, 503 
Bullmore ET, Jones PB (2008). Reinforcement and reversal learning in first-episode 504 
psychosis. Schizophrenia bulletin 34, 848-855  505 
Pantelis C, Barnes TR, Nelson HE, Tanner S, Weatherley L, Owen AM, Robbins TW 506 
(1997). Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain: A 507 
Journal Of Neurology 120 ( Pt 10), 1823-1843  508 
Pantelis C, Wood SJ, Proffitt TM, Testa R, Mahony K, Brewer WJ, Buchanan J, 509 
Velakoulis D, McGorry PD (2009). Attentional set-shifting ability in first-episode and 510 
  
24 
 
established schizophrenia: Relationship to working memory. Schizophrenia research 112, 511 
104-113  512 
Pashler H, Wagenmakers E (2012). Editors’ introduction to the special section on 513 
replicability in psychological science: A crisis of confidence?. Perspectives on Psychological 514 
Science 7, 528-530  515 
R Development Core Team R: a language and environment for statistical computing. 2013. 516 
R Foundation for Statistical Computing, Vienna, Austria. (http://www.R-project.org/)  517 
Reichenberg A, Weiser M, Rabinowitz J, Caspi A, Schmeidler J, Mark M, Kaplan Z, 518 
Davidson M (2002). A population-based cohort study of premorbid intellectual, language, 519 
and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and 520 
nonpsychotic bipolar disorder. The American Journal of Psychiatry 159, 2027-2035  521 
Robbins TW, James M, Owen AM, Sahakian BJ, Lawrence AD, McInnes L, Rabbitt 522 
PM (1998). A study of performance on tests from the CANTAB battery sensitive to frontal 523 
lobe dysfunction in a large sample of normal volunteers: implications for theories of 524 
executive functioning and cognitive aging. Cambridge Neuropsychological Test Automated 525 
Battery. Journal Of The International Neuropsychological Society: JINS 4, 474-490  526 
Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P (1994). 527 
Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study 528 
of a large sample of normal elderly volunteers. Dementia (Basel, Switzerland) 5, 266-281  529 
Robbins TW, Sahakian BJ (1994). Computer Methods of Assessment of Cognitive 530 
Function. In Principles and Practice of Geriatric Psychiatry (eds. J. R. M. Copeland, M. T. 531 
Abou-Saleh, D. G. Blazer), pp. 205-209. John Wiley & Sons, Ltd, Chichester, UK  532 
Rosseel Y (2012). Iavaan: An R Package for Structural Equation Modeling. Journal of 533 
Statistical Software 48(2), 1-36  534 
Saykin AJ, Gur RC, Gur RE, Mozley PD, Mozley LH, Resnick SM, Kester DB, 535 
Stafiniak P (1991). Neuropsychological function in schizophrenia. Selective impairment in 536 
memory and learning. Archives of General Psychiatry 48, 618-624  537 
Steiger JH (2000). Point estimation, hypothesis testing, and interval estimation using the 538 
RMSEA: Some comments and a reply to Hayduck and Glaser. Structural Equation Modeling 539 
7, 149-162  540 
Stip E, Lecardeur L, Sepehry AA (2008). Computerised Assessment of Visuo-spatial 541 
Cognition in Schizophrenia – An Exploratory Meta-analysis of CANTAB Findings. 542 
European Psychiatric Review, 48-54  543 
Townsend LA, Norman RMG (2004). Course of cognitive functioning in first episode 544 
schizophrenia spectrum disorders. Expert Review Of Neurotherapeutics 4, 61-68  545 
  
25 
 
Vandenberg RJ, Lance CE (2000). A review and synthesis of the measurement invariance 546 
literature: Suggestions, practices, and recommendations for organizational research. 547 
Organizational Research Methods 3, 4-69  548 
Wicherts JM, Dolan CV (2010). Measurement invariance in confirmatory factor analysis: 549 
An illustration using IQ test performance of minorities. Educational Measurement: Issues 550 
and Practice 29, 39-47  551 
Widaman KF, Reise SP (1997). Exploring the measurement invariance of psychological 552 
instruments: Applications in the substance use domain. In (eds. K. J. Bryant, M. Windle, S. 553 
G. West), pp. 281-324. American Psychological Association: Washington, DC US  554 
